Data reveal oncogenic scaffold function of BTK mutations that lack kinase activity and show these mutations remain susceptible to degradation by NX-2127 .
City of Hope researchers discover human ILC2s and immune cells, exhibit unprecedented cancer-killing abilities, challenge assumptions, and offer a versatile, off-the-shelf approach to revolutionize cancer immunotherapy.